These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 14737054)

  • 1. Autonomic signs and dosing during the initial stages of clozapine therapy.
    Oyewumi LK; Cernovsky ZZ; Freeman DJ
    Med Sci Monit; 2004 Feb; 10(2):PI19-23. PubMed ID: 14737054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of blood counts during clozapine treatment to serum concentrations of clozapine and nor-clozapine.
    Oyewumi LK; Cernovsky ZZ; Freeman DJ; Streiner DL
    Can J Psychiatry; 2002 Apr; 47(3):257-61. PubMed ID: 11987477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients.
    Kyllesø L; Smith RL; Karlstad Ø; Andreassen OA; Molden E
    CNS Drugs; 2021 Sep; 35(9):999-1008. PubMed ID: 34417726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of sampling time in therapeutic drug monitoring of clozapine.
    Jakobsen MI; Larsen JR; Svensson CK; Johansen SS; Linnet K; Nielsen J; Fink-Jensen A
    Acta Psychiatr Scand; 2017 Feb; 135(2):159-169. PubMed ID: 27922183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QTc prolongation and clozapine: fact or artefact?
    Nielsen J
    Aust N Z J Psychiatry; 2012 Aug; 46(8):793-4. PubMed ID: 22492267
    [No Abstract]   [Full Text] [Related]  

  • 7. Weight gain during a double-blind multidosage clozapine study.
    de Leon J; Diaz FJ; Josiassen RC; Cooper TB; Simpson GM
    J Clin Psychopharmacol; 2007 Feb; 27(1):22-7. PubMed ID: 17224708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma clozapine concentration coefficients of variation in a long-term study.
    Diaz FJ; de Leon J; Josiassen RC; Cooper TB; Simpson GM
    Schizophr Res; 2005 Jan; 72(2-3):131-5. PubMed ID: 15560958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A target-dose finding study of clozapine in patients with schizophrenia.
    Bennett JA; Keck PE
    Ann Clin Psychiatry; 1996 Mar; 8(1):19-21. PubMed ID: 8743644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine: more than 900 mg/day may be needed.
    Maccall C; Billcliff N; Igbrude W; Natynczuk S; Spencer EP; Flanagan RJ
    J Psychopharmacol; 2009 Mar; 23(2):206-10. PubMed ID: 18515467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of patients with treatment-refractory schizophrenia to clozapine within three serum level ranges.
    VanderZwaag C; McGee M; McEvoy JP; Freudenreich O; Wilson WH; Cooper TB
    Am J Psychiatry; 1996 Dec; 153(12):1579-84. PubMed ID: 8942454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
    Perry PJ; Miller DD; Arndt SV; Cadoret RJ
    Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of left ventricular function early in treatment with clozapine: a preliminary study.
    Curto M; Comparelli A; Ciavarella GM; Gasperoni C; Lionetto L; Corigliano V; Uccellini A; Mancinelli I; Ferracuti S; Girardi P; Baldessarini RJ
    Int Clin Psychopharmacol; 2015 Sep; 30(5):282-9. PubMed ID: 26049674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
    Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
    Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations of high-dose olanzapine in a double-blind crossover study.
    Kelly DL; Richardson CM; Yu Y; Conley RR
    Hum Psychopharmacol; 2006 Aug; 21(6):393-8. PubMed ID: 16850522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.
    Perry PJ; Bever KA; Arndt S; Combs MD
    Biol Psychiatry; 1998 Oct; 44(8):733-8. PubMed ID: 9798077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
    Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
    J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heart rate variability in schizophrenic patients treated with antipsychotic agents].
    Cohen H; Loewenthal U; Matar M; Kotler M
    Harefuah; 2001 Dec; 140(12):1142-7, 1231. PubMed ID: 11789296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Once-daily versus divided dosing regimens of clozapine: A cross-sectional study in Singapore.
    Yang Z; Takeuchi H; Yee JY; See YM; Tang C; Ng BT; Lee J
    Schizophr Res; 2024 Jun; 268():66-73. PubMed ID: 37833207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Pressure and Heart Rate Changes During Clozapine Treatment.
    Norman SM; Sullivan KM; Liu F; DiPaula BA; Jose PA; Kitchen CA; Feldman SM; Kelly DL
    Psychiatr Q; 2017 Sep; 88(3):545-552. PubMed ID: 27678498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.